A carregar...
A Case of Evan's Syndrome Induced by Vedolizumab
Vedolizumab is a monoclonal antibody against the ɑ4β7 integrin receptor used for the treatment of ulcerative colitis and Crohn's disease. Clinical trials have shown vedolizumab to be a safe and highly effective therapy in treating inflammatory bowel disease. Its unique gut-specific mechanism of...
Na minha lista:
| Publicado no: | ACG Case Rep J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6657984/ https://ncbi.nlm.nih.gov/pubmed/31598531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/crj.0000000000000002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|